LifeStance Health SG&A Expenses 2020-2024 | LFST

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

LifeStance Health sg&a expenses from 2020 to 2024. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

LifeStance Health sg&a expenses from 2020 to 2024. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.

Related Stocks
Company Name	Market Cap
Fresenius SE (FSNUY)	$20.6B
Quest Diagnostics (DGX)	$17.4B
DaVita (DVA)	$12.3B
Encompass Health (EHC)	$10.4B
Chemed (CHE)	$8.3B
Elanco Animal Health (ELAN)	$7.2B
RadNet (RDNT)	$5.3B
Option Care Health (OPCH)	$3.9B
Amedisys (AMED)	$3.2B
Astrana Health (ASTH)	$2.9B
Addus HomeCare (ADUS)	$2.3B
U.S Physical Therapy (USPH)	$1.4B
Pennant (PNTG)	$1.1B
Aveanna Healthcare Holdings (AVAH)	$1.1B
Atai Life Sciences (ATAI)	$227M
Daxor (DXR)	$45M
MEDIROM Healthcare Technologies (MRM)	$14M
Psychemedics (PMD)	$14M
ATI Physical Therapy (ATIP)	$13M
Ontrak (OTRK)	$8M
IMAC Holdings (BACK)	$1M